American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
-
A case of paralytic ileus in a patient receiving oral diltiazem therapy for atrial fibrillation is reported. ⋯ A 64-year-old man receiving high-dose diltiazem to treat atrial fibrillation developed paralytic ileus, which quickly resolved after the medication was discontinued.
-
Am J Health Syst Pharm · Aug 2011
Characteristics of postgraduate year 1 pharmacy residency programs at academic medical centers.
The training components and other characteristics of postgraduate year 1 (PGY1) pharmacy residency programs at a sample of academic medical centers were evaluated. ⋯ Results of this survey indicate that there is a large amount of variation in the components of PGY1 pharmacy residency programs among UHC academic medical centers. The majority of respondents reported no change in the number of residency positions offered within the past two years, but they reported an increase in the number of applications from 2009 to 2010.
-
Am J Health Syst Pharm · Jul 2011
Randomized Controlled Trial Comparative StudyCost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
Medication nonadherence due to cost issues among community-dwelling patients with end-stage renal disease (ESRD) enrolled in Medicare prescription drug plans was evaluated. ⋯ In early 2007, 31% of survey respondents with ESRD enrolled in Medicare Part D drug plans reported CRN in the preceding six months. After adjusting for potential confounders, respondents with ESRD remained 23% more likely than respondents without ESRD to report CRN in the preceding six months.
-
Published evidence on the pathophysiology, diagnosis, and treatment of fibromyalgia is reviewed, with an emphasis on recent clinical trials of various pharmacologic agents. ⋯ A broad range of drugs has been used to treat fibromyalgia. Symptoms, comorbidities, adverse effects, and patient preference are important considerations in drug selection.
-
Am J Health Syst Pharm · Jul 2011
ReviewRapid-sequence intubation and the role of the emergency department pharmacist.
The pharmacology, pharmacokinetics, safety, and dosing of medications used during the pretreatment and paralysis with induction steps of rapid-sequence intubation (RSI) and the role of the pharmacist in RSI are reviewed. ⋯ The selection of an appropriate sedative and neuromuscular blocker during the pretreatment and paralysis with induction steps of RSI can be facilitated by an ED pharmacist.